ticlopidine has been researched along with Overweight in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overweight or obese patients exhibit poorer platelet responses to clopidogrel." | 8.12 | Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice. ( Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T, 2022) |
| "Overweight or obese patients exhibit poorer platelet responses to clopidogrel." | 4.12 | Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice. ( Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puccini, M | 1 |
| Rauch, C | 1 |
| Jakobs, K | 1 |
| Friebel, J | 1 |
| Hassanein, A | 1 |
| Landmesser, U | 1 |
| Rauch, U | 1 |
| Jiang, LP | 1 |
| Ji, JZ | 1 |
| Ge, PX | 1 |
| Zhu, T | 1 |
| Mi, QY | 1 |
| Tai, T | 1 |
| Li, YF | 1 |
| Xie, HG | 1 |
2 other studies available for ticlopidine and Overweight
| Article | Year |
|---|---|
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Clopidogrel; Humans; Obesity; Overweight | 2023 |
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice.
Topics: Animals; Blood Platelets; Clopidogrel; Humans; Mice; Obesity; Overweight; Platelet Aggregation; Plat | 2022 |